Bellicum Pharmaceuticals, Inc

Ownership Transactions Reported by 10 Insiders

Industry
Pharmaceutical Preparations
Location
3730 Kirby Drive, Suite 1200, Houston, TX

There are no Buy or Sell transactions made by insiders since 9/13/2023

Bellicum Pharmaceuticals, Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Richard A. Fair President and CEO, Director $576K Aug 15, 2022
Charity Scripture Chief Development Officer $360K Aug 15, 2022
Stephen Davis Director $21.6K Jan 3, 2023
James M. Daly Director $21.6K Jan 3, 2023
Judith V. Klimovsky Director $21.6K Jan 3, 2023
Reid M. Huber Director $21.6K Jan 3, 2023
Jon P. Stonehouse Director $21.6K Jan 3, 2023
James F. Brown Director $9.36K Jan 4, 2022
S. Grass Principal Accounting Officer May 11, 2021
Baker Bros. Advisors Lp 10%+ Owner Nov 22, 2023

Recent Insider Transactions by Companies or Individuals for Bellicum Pharmaceuticals, Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.